Browse studies

Find your next paid study

1 recruiting study matching your filters

A Phase 1, Open-Label, Non-randomized, Single Dose, Safety, Tolerability, and Pharmacokinetic Study of Vorasidenib Administered to Participants With Severe Hepatic Impairment and Matched-Participants With Normal Hepatic Function

The objective of this study is to evaluate the pharmacokinetics, safety, and tolerability of one dose of vorasidenib in participants with severe impaired hepat…

Severe Hepatic ImpairmentNormal Hepatic Function

Estimated

~$10 – $7,500

Institut de Recherches Internationales Servier (I.R.I.S.)NCT07250633